All analyses were performed using TriNetX built-in analytic tools, with external validation as appropriate
If you experience significant gastrointestinal side effects at lower doses, dose timing adjustments, food composition changes, or slower titration schedules may improve tolerability while maintaining efficacy
ANZCA Clinical Practice Recommendations regarding patients taking GLP-1 receptor agonists and dual GLP-1/GIP receptor co-agonists prior to anaesthesia or sedation for surgical and endoscopic procedures
It is particularly important for intensive aquaculture animals, because environmental pressures may cause significant losses to fish growers
Keeping your heart healthy can be hard
Stroke reduction In 2022, physician David Strain and colleagues reported an analysis of two clinical trials that measured the cardiovascular benefits of semaglutide in people with type 2 diabetes and high cardiovascular risk